Eva King Killam
Eva King Killam (1919–1995) was a pioneering neuroscientist and pharmacologist known for her significant contributions to the field of neuropharmacology. She was one of the first scientists to use radioactive isotopes in the study of brain chemistry, which led to groundbreaking discoveries about the function of neurotransmitters in the brain.
Early Life and Education[edit | edit source]
Eva King was born in 1919 in New York City. She completed her undergraduate studies at Hunter College in 1940, majoring in chemistry. She then pursued her graduate studies at Columbia University, where she earned her Ph.D. in biochemistry in 1944.
Career[edit | edit source]
After completing her Ph.D., Killam began her career at the Brookhaven National Laboratory, where she was one of the first scientists to use radioactive isotopes to study brain chemistry. Her research focused on the role of neurotransmitters in the brain, particularly dopamine and serotonin.
In 1956, she moved to the University of California, Berkeley, where she continued her research in neuropharmacology. She was appointed as a professor in the Department of Pharmacology in 1967, making her the first woman to hold a professorship in that department.
Contributions to Neuroscience[edit | edit source]
Killam's research has had a profound impact on the field of neuroscience. Her work on neurotransmitters has helped to elucidate the biochemical basis of mental illness and has contributed to the development of new treatments for conditions such as schizophrenia and depression.
Personal Life[edit | edit source]
Eva King married fellow scientist Keith Killam in 1946. They collaborated on many research projects throughout their careers.
Death and Legacy[edit | edit source]
Eva King Killam died in 1995. Her contributions to neuroscience and pharmacology continue to be recognized and have paved the way for future research in these fields.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD